SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

____________________________

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): May 17, 2011

____________________________

 

Quest Diagnostics Incorporated

(Exact Name of Registrant as Specified in Its Charter)

___________________________

 

Delaware

(State or other jurisdiction of Incorporation)

 

001-12215		16-1387862
(Commission File Number)		(I.R.S. Employer Identification No.)
Three Giralda Farms Madison, NJ 07940		07940
(Address of principal executive offices)		(Zip Code)
(973) 520-2700
(Registrant’s telephone number, including area code)

 

___________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction a.2. below):

 

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

Item 5.07. Submission of Matters to a Vote of Security Holders

 

(a)	The Annual Meeting of Shareholders of the Quest Diagnostics Incorporated (the “Company”) was held on May 17, 2011.
(b)	The following nominees for the office of director were elected for terms expiring at the 2014 Annual Meeting of Shareholders, by the following votes:

 

	For		Against		Abstain		Broker Non-Vote
William F. Buehler	112,629,856		4,869,437		329,644		10,199,580
Daniel C. Stanzione, Ph.D.	112,591,514		4,910,717		326,708		10,199,758

 

	The following persons also continue as directors:
	John C. Baldwin, M.D.
	Jenne K. Britell, Ph.D.
	Gary M. Pfeiffer
	Surya N. Mohapatra, Ph.D.
	Gail R. Wilensky, Ph.D.
	John B. Ziegler

 

The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm to audit the financial statements of the Company and its subsidiaries for the fiscal year ending December 31, 2011 was approved by the following votes:

 

For		Against		Abstain
125,975,806		1,725,298		327,413

 

The advisory vote on the compensation of the Company’s named executive officers was as follows:

 

For		Against		Abstain		Broker Non-Vote
108,823,528		7,795,730		1,209,677		10,199,582

 

The advisory vote on the frequency of future advisory votes on executive compensation was as follows:

 

3 Years		2 Years		1 Year		Abstain		Broker Non-Vote
22,916,331		2,148,406		92,299,636		463,753		10,200,391

---

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

	May 20, 2011
	QUEST DIAGNOSTICS INCORPORATED
	By:	/s/ William J. O’Shaughnessy, Jr.
		William J. O’Shaughnessy, Jr.
		Assistant General Counsel and Secretary

---